Recursion Pharmaceuticals Inc
NASDAQ:RXRX

Watchlist Manager
Recursion Pharmaceuticals Inc Logo
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Watchlist
Price: 5.28 USD Market Closed
Market Cap: 2.1B USD

Wall Street
Price Targets

RXRX Price Targets Summary
Recursion Pharmaceuticals Inc

Wall Street analysts forecast RXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXRX is 6.63 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

Lowest
Price Target
3.03 USD
43% Downside
Average
Price Target
6.63 USD
26% Upside
Highest
Price Target
10.5 USD
99% Upside
Recursion Pharmaceuticals Inc Competitors:
Price Targets
DVAX
Dynavax Technologies Corp
126% Upside
TLX
Telix Pharmaceuticals Ltd
43% Upside
VYGR
Voyager Therapeutics Inc
376% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
20% Upside
005690
Pharmicell Co Ltd
29% Upside
KALV
Kalvista Pharmaceuticals Inc
83% Upside
CDNA
CareDx Inc
48% Upside

Revenue
Forecast

Revenue Estimate
Recursion Pharmaceuticals Inc

For the last 4 years the compound annual growth rate for Recursion Pharmaceuticals Inc's revenue is 96%. The projected CAGR for the next 3 years is 56%.

96%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Recursion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Recursion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXRX's stock price target?
Price Target
6.63 USD

According to Wall Street analysts, the average 1-year price target for RXRX is 6.63 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

What is Recursion Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
56%

For the last 4 years the compound annual growth rate for Recursion Pharmaceuticals Inc's revenue is 96%. The projected CAGR for the next 3 years is 56%.

Back to Top